These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 26060190)
21. Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome. Glineburg MR; Todd PK; Charlet-Berguerand N; Sellier C Brain Res; 2018 Aug; 1693(Pt A):43-54. PubMed ID: 29453961 [TBL] [Abstract][Full Text] [Related]
22. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Van Dam D; Errijgers V; Kooy RF; Willemsen R; Mientjes E; Oostra BA; De Deyn PP Behav Brain Res; 2005 Jul; 162(2):233-9. PubMed ID: 15876460 [TBL] [Abstract][Full Text] [Related]
23. Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice. Foote M; Arque G; Berman RF; Santos M Cerebellum; 2016 Oct; 15(5):611-22. PubMed ID: 27255703 [TBL] [Abstract][Full Text] [Related]
24. CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. Brouwer JR; Huizer K; Severijnen LA; Hukema RK; Berman RF; Oostra BA; Willemsen R J Neurochem; 2008 Dec; 107(6):1671-82. PubMed ID: 19014369 [TBL] [Abstract][Full Text] [Related]
25. Lack of a Clear Behavioral Phenotype in an Inducible FXTAS Mouse Model Despite the Presence of Neuronal FMRpolyG-Positive Aggregates. Haify SN; Mankoe RSD; Boumeester V; van der Toorn EC; Verhagen RFM; Willemsen R; Hukema RK; Bosman LWJ Front Mol Biosci; 2020; 7():599101. PubMed ID: 33381520 [TBL] [Abstract][Full Text] [Related]
26. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Todd PK; Oh SY; Krans A; He F; Sellier C; Frazer M; Renoux AJ; Chen KC; Scaglione KM; Basrur V; Elenitoba-Johnson K; Vonsattel JP; Louis ED; Sutton MA; Taylor JP; Mills RE; Charlet-Berguerand N; Paulson HL Neuron; 2013 May; 78(3):440-55. PubMed ID: 23602499 [TBL] [Abstract][Full Text] [Related]
27. Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development. Botta-Orfila T; Tartaglia GG; Michalon A Cerebellum; 2016 Oct; 15(5):599-610. PubMed ID: 27277287 [TBL] [Abstract][Full Text] [Related]
28. Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Sofola OA; Jin P; Botas J; Nelson DL Hum Mol Genet; 2007 Oct; 16(19):2326-32. PubMed ID: 17635840 [TBL] [Abstract][Full Text] [Related]
38. [Late cerebellar ataxia associated with fragile X premutation]. Chaussenot A; Borg M; Bayreuther C; Lebrun C Rev Neurol (Paris); 2008 Nov; 164(11):957-63. PubMed ID: 18808779 [TBL] [Abstract][Full Text] [Related]
39. Reversible encephalitis-like episodes in fragile X-associated tremor/ataxia syndrome: a case report. Zhong S; Liu J; Lian Y; Zhou B; Wang X; Ding J BMC Neurol; 2024 May; 24(1):154. PubMed ID: 38714961 [TBL] [Abstract][Full Text] [Related]
40. Neurodegeneration of White and Gray Matter in the Hippocampus with FXTAS. Kargar M; Hagerman RJ; Martínez-Cerdeño V Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]